| Trevor Batty, DO | |
|
147 W Chubbuck Rd, Chubbuck, ID 83202-2314 | |
| (208) 238-7546 | |
| (208) 237-9643 |
| Full Name | Trevor Batty |
|---|---|
| Gender | Male |
| Speciality | Dermatology |
| Experience | 9 Years |
| Location | 147 W Chubbuck Rd, Chubbuck, Idaho |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1558756106 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207N00000X | Dermatology | O-1245 (Idaho) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Portneuf Medical Center | Pocatello, ID | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Idaho Skin Institute Of Chubbuck | 0648658807 | 4 |
News Archive
In a two-day conference organised in collaboration between the Maltese Presidency of the Council of the European Union and ECDC, HIV experts from across the European Union discussed how to reverse this trend and how to prepare Europe to achieve the set target of ending AIDS by 2030.
Before modern medical lab techniques became available, doctors diagnosed some diseases by smelling a patient's breath. Scientists have been working for years to develop analytical instruments that can mimic this sniff-and-diagnose ability.
Pfizer announced today that the U.S. Food and Drug Administration (FDA) has approved Revatio® (sildenafil) Injection, an intravenous formulation of Revatio. Revatio is the only FDA-approved phosphodiesterase-5 (PDE5) inhibitor available in both tablet and intravenous formulations.
The Norwegian Academy of Science and Letters, in partnership with The Kavli Foundation and the Norwegian Ministry of Education and Research, has announced the establishment of the Kavli Prize Science Forum - a new biennial international forum meeting to facilitate high-level, global discussion of major topics on science and science policy.
› Verified 6 days ago
| Entity Name | Stoddard Medical Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1972745594 PECOS PAC ID: 0840341517 Enrollment ID: O20090620000023 |
News Archive
In a two-day conference organised in collaboration between the Maltese Presidency of the Council of the European Union and ECDC, HIV experts from across the European Union discussed how to reverse this trend and how to prepare Europe to achieve the set target of ending AIDS by 2030.
Before modern medical lab techniques became available, doctors diagnosed some diseases by smelling a patient's breath. Scientists have been working for years to develop analytical instruments that can mimic this sniff-and-diagnose ability.
Pfizer announced today that the U.S. Food and Drug Administration (FDA) has approved Revatio® (sildenafil) Injection, an intravenous formulation of Revatio. Revatio is the only FDA-approved phosphodiesterase-5 (PDE5) inhibitor available in both tablet and intravenous formulations.
The Norwegian Academy of Science and Letters, in partnership with The Kavli Foundation and the Norwegian Ministry of Education and Research, has announced the establishment of the Kavli Prize Science Forum - a new biennial international forum meeting to facilitate high-level, global discussion of major topics on science and science policy.
› Verified 6 days ago
| Entity Name | Stoddard & Bingham Medical Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1457912107 PECOS PAC ID: 0547590168 Enrollment ID: O20190925001142 |
News Archive
In a two-day conference organised in collaboration between the Maltese Presidency of the Council of the European Union and ECDC, HIV experts from across the European Union discussed how to reverse this trend and how to prepare Europe to achieve the set target of ending AIDS by 2030.
Before modern medical lab techniques became available, doctors diagnosed some diseases by smelling a patient's breath. Scientists have been working for years to develop analytical instruments that can mimic this sniff-and-diagnose ability.
Pfizer announced today that the U.S. Food and Drug Administration (FDA) has approved Revatio® (sildenafil) Injection, an intravenous formulation of Revatio. Revatio is the only FDA-approved phosphodiesterase-5 (PDE5) inhibitor available in both tablet and intravenous formulations.
The Norwegian Academy of Science and Letters, in partnership with The Kavli Foundation and the Norwegian Ministry of Education and Research, has announced the establishment of the Kavli Prize Science Forum - a new biennial international forum meeting to facilitate high-level, global discussion of major topics on science and science policy.
› Verified 6 days ago
| Entity Name | Stoddard & Bingham Medical Of Twin Falls Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1114691813 PECOS PAC ID: 7517364920 Enrollment ID: O20210928002801 |
News Archive
In a two-day conference organised in collaboration between the Maltese Presidency of the Council of the European Union and ECDC, HIV experts from across the European Union discussed how to reverse this trend and how to prepare Europe to achieve the set target of ending AIDS by 2030.
Before modern medical lab techniques became available, doctors diagnosed some diseases by smelling a patient's breath. Scientists have been working for years to develop analytical instruments that can mimic this sniff-and-diagnose ability.
Pfizer announced today that the U.S. Food and Drug Administration (FDA) has approved Revatio® (sildenafil) Injection, an intravenous formulation of Revatio. Revatio is the only FDA-approved phosphodiesterase-5 (PDE5) inhibitor available in both tablet and intravenous formulations.
The Norwegian Academy of Science and Letters, in partnership with The Kavli Foundation and the Norwegian Ministry of Education and Research, has announced the establishment of the Kavli Prize Science Forum - a new biennial international forum meeting to facilitate high-level, global discussion of major topics on science and science policy.
› Verified 6 days ago
| Entity Name | Idaho Skin Institute Of Chubbuck |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1184375867 PECOS PAC ID: 0648658807 Enrollment ID: O20220601000825 |
News Archive
In a two-day conference organised in collaboration between the Maltese Presidency of the Council of the European Union and ECDC, HIV experts from across the European Union discussed how to reverse this trend and how to prepare Europe to achieve the set target of ending AIDS by 2030.
Before modern medical lab techniques became available, doctors diagnosed some diseases by smelling a patient's breath. Scientists have been working for years to develop analytical instruments that can mimic this sniff-and-diagnose ability.
Pfizer announced today that the U.S. Food and Drug Administration (FDA) has approved Revatio® (sildenafil) Injection, an intravenous formulation of Revatio. Revatio is the only FDA-approved phosphodiesterase-5 (PDE5) inhibitor available in both tablet and intravenous formulations.
The Norwegian Academy of Science and Letters, in partnership with The Kavli Foundation and the Norwegian Ministry of Education and Research, has announced the establishment of the Kavli Prize Science Forum - a new biennial international forum meeting to facilitate high-level, global discussion of major topics on science and science policy.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Trevor Batty, DO 147 W Chubbuck Rd, Chubbuck, ID 83202-2314 Ph: (208) 238-7546 | Trevor Batty, DO 147 W Chubbuck Rd, Chubbuck, ID 83202-2314 Ph: (208) 238-7546 |
News Archive
In a two-day conference organised in collaboration between the Maltese Presidency of the Council of the European Union and ECDC, HIV experts from across the European Union discussed how to reverse this trend and how to prepare Europe to achieve the set target of ending AIDS by 2030.
Before modern medical lab techniques became available, doctors diagnosed some diseases by smelling a patient's breath. Scientists have been working for years to develop analytical instruments that can mimic this sniff-and-diagnose ability.
Pfizer announced today that the U.S. Food and Drug Administration (FDA) has approved Revatio® (sildenafil) Injection, an intravenous formulation of Revatio. Revatio is the only FDA-approved phosphodiesterase-5 (PDE5) inhibitor available in both tablet and intravenous formulations.
The Norwegian Academy of Science and Letters, in partnership with The Kavli Foundation and the Norwegian Ministry of Education and Research, has announced the establishment of the Kavli Prize Science Forum - a new biennial international forum meeting to facilitate high-level, global discussion of major topics on science and science policy.
› Verified 6 days ago
Earl Stoddard, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 147 W Chubbuck Rd, Chubbuck, ID 83202 Phone: 208-238-7546 Fax: 208-237-9643 |